OpenAI has added a feature to its Codex macOS app that changes the barrier to AI-powered automation: instead of writing a prompt or configuring a workflow, a user performs a task while Codex watches, ...

Brighton fans have been getting in touch with BBC Radio Sussex as the Seagulls celebrate their 125-year anniversary during ...

Google Vids is removing its paid subscription requirement, allowing personal account holders to use AI avatars and Veo video ...

MiniMax unveiled Hub, a multimodal AI tool combining video, image, voiceover and editing, at Shanghai International Film ...

Today's game between Ajax and PSV Eindhoven will kick-off at May 2, 2026, 2:00 PM. TV channel and live stream options for Ajax vs PSV Eindhoven are listed below. In the United States, the match is ...

Trials of the British Army's Ajax armoured vehicle will be "proceeding cautiously" after they were halted last year, a defence minister has said. A decision was made to stop using the Ajax after ...

LONDON, April 28 (Reuters) - Britain's defence readiness minister Luke Pollard said he had agreed to restart the army's acceptance of Ajax armoured vehicles from General Dynamics with ‌strict controls ...

General Dynamics said the safety of soldiers 'is, and has always been, our highest priority'. Trials of the Army's troubled Ajax armoured vehicles will resume "cautiously", with the defence minister ...

Eli Lilly said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up to $2.3 billion in cash, as the U.S. drugmaker looks to expand its oncology pipeline. Lilly has been ...

April 27 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up ‌to $2.3 billion in cash, as the U.S. drugmaker looks to ...

Eli Lilly’s run of near-weekly acquisitions still shows no sign of letting up, with the Big Pharma now buying Ajax Therapeutics for its clinical-stage myelofibrosis therapy. At the center of the deal ...

Total consideration reaches up to $2.3 billion via upfront payment plus milestones tied to predefined clinical and regulatory achievements, subject to customary conditions and Hart-Scott-Rodino ...